Developed Tendinitis from a Vaccine?

According to extensive research and surveillance systems, vaccine injuries are relatively rare. The Centers for Disease Control and Prevention (CDC) closely monitors vaccine safety through the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD), among other systems. These systems enable continuous monitoring of adverse events following immunization, allowing for the detection of any potential safety concerns.

According to the National Vaccine Injury Compensation Program (VICP), which compensates individuals injured by vaccines, less than 1% of vaccine doses result in adverse reactions. These reactions range from mild, such as soreness at the injection site, to more severe but still rare, such as an allergic reaction.

Various studies have shown that adverse events following vaccination are extremely low. For example, a Vaccine Safety Datalink study reports that severe allergic reactions (known as anaphylaxis) occur at a rate of about 1.31 per million doses administered for vaccines recommended for children and adults.

Other serious adverse events, such as encephalitis and Guillain-Barre Syndrome, are even rarer, with rates ranging from less than one per million to one per several million doses administered.

If you or a loved one experiences severe side effects after a meningococcal vaccine, it’s important to keep detailed records to be used as evidence down the line. Medical documents and bills should be copied or scanned so you have backups. Then, speak to a lawyer.

They can advise you on whether you have a claim and help you gather and organize the evidence and start the filing process. In a time that’s likely filled with stress, fear, and sadness, it’s important to have someone who knows the rules and procedures on your side.

There are two types of meningococcal vaccines, MenACWY and MenB:

• MenACWY should be given to teens and pre-teens; a booster dose should be given 4-5 years after the initial vaccine.
• MenB vaccines may be given to older teens between 16 and 18. The vaccine is typically administered in 2 doses.

For children younger than 10 and adults, MenACWY is only recommended for patients with certain risk factors. Likewise, MenB may be administered to children over 10 and adults who are at higher risk for certain types of meningitis.

Diphtheria, Tetanus, Flu (Influenza), Hepatitis A, Hepatitis B, Human Papillomavirus (HPV), Measles, Mumps, Rubella (MMR), Meningococcal, Pneumococcal, Polio, Rotavirus, and Varicella (Chickenpox).

For more information on vaccines included under the VICP, visit our page on Vaccines covered by the National Vaccine Injury Compensation Program (VICP).